Family-Based Behavioral Medical Nutrition Therapy Education in Children and Adolescents With Type 1 Diabetes

June 6, 2022 updated by: Hulya Yilmaz, Hasan Kalyoncu University

The Effect of Family-Based Behavioral Medical Nutrition Therapy Education on Nutritional Status and Metabolic Control in Children and Adolescents With Type 1 Diabetes

Type 1 Diabetes Mellitus (T1DM) is a heterogeneous condition and is an absolute insulin deficiency resulting from autoimmune-mediated destruction of pancreatic β-cells (1). The incidence of T1DM has been increasing globally since the 1950s, particularly in children, with an average annual increase of 3-4% over the past three decades.Despite the advances in medical treatment and technology, nutritional therapy continues to be the main component of diabetes treatment. Medical nutrition further improves metabolic control outcomes when T1DM care is combined with other treatments.This study was conducted to examine the effect of family-based behavioral medical nutrition therapy training on nutritional status and metabolic control in children and adolescents with Type 1 diabetes.

Study Overview

Detailed Description

The research was carried out with children and adolescents aged 8-18 years who were followed up with the diagnosis of Type 1 Diabetes Mellitus in Gaziantep Cengiz Gökçek Gynecology and Pediatrics Hospital. The sample of the study was consisted of 75 (male= 36, female= 39) children and adolescents in total, including Intervention 1 group (n=25), Intervention 2 (n=25) group and Control (n=25) group determined by double-blind, stratified, random method. Medical nutrition therapy and carbohydrate counting training were given to mothers and children in the Intervention 1 group, and only to children and adolescents in the Intervention 2 group. The control group did not receive medical nutrition therapy and carbohydrate counting training. At the beginning (0. month) and at the end (6. month) of the study, 3 consecutive day/24-hour food consumption records and anthropometric measurements of the individuals were assessed, BMI z-scores and height z-scores were calculated, Mediterranean Diet Quality Index Scale (KIDMED), Diabetes Eating Problems Survey-Revised (DEPS-R), Physical Activity Questionnaire for Children and Adolescents (PAQ-C and PAQ-A) were administered and Healthy Eating Index 2015 (HEI-2015) scores were calculated. Routinely assessed blood findings of the individuals were checked at the beginning (0. month), 3rd month and 6th month of the study.

Study Type

Interventional

Enrollment (Actual)

75

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Gaziantep, Turkey, 27010
        • Gaziantep Cengiz Gokcek Gynecology and Pediatrics Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

8 years to 18 years (Child, Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

All

Description

Inclusion Criteria:

  • 8-18 years old,
  • Being diagnosed with T1DM for at least ≥1 year, maximum ≤5 years,
  • Latest HbA1c ≥6.5% - <13.5%,
  • Receiving intensive insulin therapy (at least 3 times a day bolus and 1 time basal insulin administration or using an insulin pump),
  • No communication problems
  • Children and adolescents without any other disease accompanying diabetes were included in the study.

Exclusion Criteria:

  • Celiac, cystic fibrosis etc. with gastrointestinal diseases,
  • Using any drug that may affect glucose metabolism,
  • Switched from an insulin pen to an insulin pump in less than 6 months,
  • Involved in any other intervention work in the last 6 months,
  • and individuals with communication problems were not included in the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: Quadruple

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Experimental: education-mother and child dyad
Mother and child dyad have received dietary intervention for 6 months
Children and their mothers have received family-based behavioral medical nutrition therapy and carbohydrate counting education for 6 months by trained dietitian
Only children have received family-based behavioral medical nutrition therapy and carbohydrate counting education for 6 months by trained dietitian
Experimental: education-only child
Children have received dietary intervention for 6 months. But their mothers didn't receive any dietary intervention
Children and their mothers have received family-based behavioral medical nutrition therapy and carbohydrate counting education for 6 months by trained dietitian
Only children have received family-based behavioral medical nutrition therapy and carbohydrate counting education for 6 months by trained dietitian
Experimental: control
Control group did't receive any dietary intervention during the study
Control group didn't receive any intervention by trained dietitian. Furthermore they continued their routine health controls.

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in mean of HbA1c from baseline to 6 months
Time Frame: 6 months
All data were analysed by using IBM SPSS Statistics 26 and significance was defined as p< 0.05
6 months

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Change in mean of Healthy Eating Index 2015 (HEI-2015) score from baseline to 6 Months
Time Frame: 6 months
All data were analysed by using IBM SPSS Statistics 26 and significance was defined as p< 0.05
6 months
Change in mean of Mediterranean Diet Quality Index Scale (KIDMED) from baseline to 6 Months
Time Frame: 6 months
All data were analysed by using IBM SPSS Statistics 26 and significance was defined as p< 0.05
6 months

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Gulden KOKSAL, Prof., Hasan Kalyoncu University

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

August 13, 2020

Primary Completion (Actual)

January 28, 2021

Study Completion (Actual)

September 15, 2021

Study Registration Dates

First Submitted

May 30, 2022

First Submitted That Met QC Criteria

June 6, 2022

First Posted (Actual)

June 9, 2022

Study Record Updates

Last Update Posted (Actual)

June 9, 2022

Last Update Submitted That Met QC Criteria

June 6, 2022

Last Verified

June 1, 2022

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

No

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Type1diabetes

Clinical Trials on Medical nutrition therapy and carbohydrate counting education

3
Subscribe